CRU 2023: Navigating challenges in corneal irregularities
September 8th 2023Brooke Messer, OD, FAAO, FSLS, shares her anticipation for the second annual CRU Eye Symposium, emphasizing its focus on pertinent content, actionable practice enhancements, and networking with peers and industry representatives, all in the setting of Napa Valley's wine country.
Paul Hahn, MD, PhD, shared insights on research comparing the relative efficacy of pegcetacoplan versus avacincaptad pegol in patients with geographic atrophy presented at the 2023 ASRS annual meeting.
CRU 2023: Learn to care for your patients' retinas with genetic testing
The 2023 CRU Eye Symposium in Napa Valley brings exciting presentation topics, including the retina and genetic testing.
FDA approves XDEMVY, the first and only treatment for Demodex blepharitis
Dr Selina McGee, OD, FAAO, Dipl ABO, met with Optometry Times to discuss the recent FDA approval of XDEMVY, a treatment for Demodex blepharitis, from Tarsus Pharmaceuticals.
EyeCon 2023: Bringing collaborative OD and MD education to life
Hear from A. Paul Chous, OD, MA, FAAO, and what to look forward to during the 2023 EyeCon meeting December 1-2 in Sanibel Harbour, FL.